Literature DB >> 1835722

Activity of vancomycin and teicoplanin against human polymorphonuclear leucocytes: a comparative study.

F J Morán1, L F Puente, C Pérez-Giraldo, M T Blanco, C Hurtado, A C Gómez-García.   

Abstract

The in-vitro effects of therapeutic concentrations of teicoplanin and vancomycin on the adherence, spontaneous mobility, chemotaxis, phagocytic and candidacidal capacity of human polymorphonuclear leukocytes (PMNs) were studied. Adherence was not affected by the tested concentrations of teicoplanin. A progressive diminishing of adherence was observed in relation to the control, which reached 30% with the maximum concentration of vancomycin (50 mg/L), although this was not statistically significant. An increase in spontaneous mobility was noted after 30 min incubation in the presence of any one of the tested concentrations of both antibiotics, although the results were only significant (P less than 0.05) for 50 mg/L of teicoplanin. Chemotaxis increased, although not significantly (P greater than 0.05) in the presence of 10 and 50 mg/L of teicoplanin, and diminished with respect to the control very significantly (P less than 0.019) when 1 and 50 mg/L of vancomycin were tested. The study of the phagocytic and candidacidal capacity of the PMNs on Candida albicans showed that teicoplanin had a favourable effect on both functions, even though the differences were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835722     DOI: 10.1093/jac/28.3.415

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Perioperative variation in phagocytic activity against Candida albicans measured by a flow-cytometric assay in cardiovascular-surgery patients.

Authors:  T L Tran; P Auger; A R Marchand; M Carrier; C Pelletier
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  [Modification of phagocytic microbicide function by antifungal agents--measuring luminol enhanced chemoluminescence in full blood].

Authors:  L Wilhelm; E Wilhelm; H Thomas; H Bernhardt
Journal:  Langenbecks Arch Chir       Date:  1996

Review 3.  Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; D H Peters
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

4.  Contrasting effects of linezolid on healthy and dysfunctional human neutrophils: reducing C5a-induced injury.

Authors:  Stephen J Evans; Aled E L Roberts; Andrew Conway Morris; A John Simpson; Llinos G Harris; Dietrich Mack; Rowena E Jenkins; Thomas S Wilkinson
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.